Prostate Cancer - Results from #200

Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional sampling. December 14, 2022

Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer. December 14, 2022

Novartis Receives European Commission Approval for Pluvicto® as the First Targeted Radioligand Therapy for Treatment of Progressive PSMA–positive Metastatic Castration-Resistant Prostate Cancer December 13, 2022

Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer. December 13, 2022

The Impact of Exercise on Improving Body Composition and PSA in High-Risk Prostate Cancer Patients on Androgen-Deprivation Therapy. December 13, 2022

CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer. December 13, 2022

Assessment of the epidemiological trends for prostate cancer using administrative data in Ontario. December 13, 2022

When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level. December 13, 2022

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022. December 13, 2022

PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry. December 13, 2022

European Health Union: Commission Welcomes Adoption of New EU Cancer Screening Recommendations December 12, 2022

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only. December 12, 2022

Safety and Efficacy of CT-Guided Percutaneous Biopsy of Suspicious Subcentimeter Pelvic and Retroperitoneal Lymph Nodes Detected by 11C-Choline PET in Patients With Prostate Cancer. December 12, 2022

Long-Term Outcomes following Active Surveillance of Low-Grade Prostate Cancer: A Population-Based Study Using a Landmark Approach. December 12, 2022

MRI-only radiotherapy from an economic perspective: Can new techniques in prostate cancer treatment be cost saving? December 12, 2022

The Experiences and Unmet Supportive Care Needs of Partners of Men Diagnosed With Prostate Cancer: A Meta-aggregation Systematic Review. December 12, 2022

Systematic review of methods used to improve the efficacy of magnetic resonance in early detection of clinically significant prostate cancer. December 9, 2022

Prediction of prostate cancer recurrence after radiation therapy using multiparametric magnetic resonance imaging and spectroscopy: assessment of prognostic factors on pretreatment imaging. December 9, 2022

Systematic review of self-management programs for prostate cancer patients, a quality of life and self-efficacy meta-analysis. December 9, 2022

Combination of PI-RADS score and PSAD can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies. December 9, 2022

Page 11 of 1276

email news signup